2020 annual financial data
Relmada Therapeutics 2020 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -60,838,673 USD and net income was -59,456,394 USD.
Operating cash flow was -27,808,801 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -60,838,673 USD
- Net income
- -59,456,394 USD
- Operating cash flow
- -27,808,801 USD